Plant-Based Diet Shows Promise in Slowing Progression of Multiple Myeloma, new Study finds
A high-fiber, plant-focused diet may offer a novel approach too managing multiple myeloma, a blood cancer affecting thousands worldwide, according to groundbreaking research published in Cancer Revelation. The international study suggests that dietary intervention can positively influence biological mechanisms, potentially delaying the disease’s progression.
A new Weapon in the Fight Against Blood Cancer
For years, patients with pre-cancerous conditions linked to multiple myeloma have faced a period of anxious monitoring.Now, a team led by Matteo Bellone of the Irccs San raffaele hospital in Milan, Italy, adn Urvi A. Shah of the Memorial Sloan Kettering Cancer Centre in New York, has demonstrated that a structured nutritional approach can impact the underlying mechanisms of the disease. “For the first time we have demonstrated that a structured nutritional intervention can impact the mechanisms underlying myeloma progression,” explained Bellone.
Multiple myeloma impacts plasma cells, a type of white blood cell, causing them to proliferate uncontrollably. Conditions like monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are often precursors to the full-blown disease, and patients with these conditions are monitored for signs of progression. Traditionally, intervention has focused on pharmaceutical treatments, but this new research explores whether lifestyle changes – specifically, diet – could play a role, or even reverse, the process?
The recent clinical trial, dubbed ‘Nutrivention,’ involved 23 participants with MGUS or SMM and a high body mass index. Over 12 weeks, participants followed a high-fiber diet rich in fruits, vegetables, legumes, and whole grains – without restricting calorie intake. The study revealed that this dietary shift was not only enduring but also well-tolerated, with over 70% of participants continuing the regimen beyond the trial period.
Positive Biological Shifts
Data collected, including food diaries maintained by participants, indicated a cascade of positive changes. Participants experienced reduced body weight, improved insulin sensitivity, decreased inflammation, and an enrichment of the gut flora with bacteria producing butyrate, a short-chain fatty acid known for its anti-inflammatory and anti-tumor properties.
While not specifically designed to assess disease progression, analysis of eight patients revealed stabilization of the monoclonal component (M-spike) – a key indicator of myeloma progression – and even advancement in two cases. “It’s as if the disease, accustomed to running slowly but inexorably, had found an unexpected obstacle on the path,” Bellone commented.
From Mouse Models to Human Impact
To understand why the diet was proving effective, researchers conducted parallel studies using mouse models. Feeding mice a high-fiber diet altered their gut microbiome, increasing butyrate production. This, in turn, reduced disease aggressiveness in the animal model and slowed the proliferation of tumor cells in laboratory cultures. The diet also reshaped immune cells in the bone marrow, redirecting them towards anti-tumor activity.
Bellone explained the process as a “cascade effect: from food to the microbiome, from the microbiota to the immune system, from the immune system to the tumor.” He theorized that butyrate, produced by gut bacteria, may reach the bone marrow and redirect immune cell behavior, slowing malignant cell proliferation.
Future Directions and Combined Therapies
The findings pave the way for larger clinical studies,personalized dietary interventions,and potential combinations with existing myeloma therapies. Researchers emphasize that this approach isn’t intended to replace conventional cancer treatments, but rather to support, accompany, and enhance them by addressing a frequently overlooked aspect of patient care: lifestyle.
A new multicenter clinical study, led by San Raffaele in Italy, has already been launched to expand upon these results. Supported by the Airc Foundation for cancer research,the study will investigate whether plant-based diets substantially alter the gut microbiota and increase short-chain fatty acid production in patients with SMM,nonetheless of body weight.
“Our objective is to transform a daily gesture,such as eating,into a scientifically solid prevention tool,” Bellone concluded. “It is indeed a path that requires rigor, but which can change the quality and life perspective of thousands of people.” The research was supported by a consortium of organizations including AIRC, Blood Cancer United, and the National Institutes of Health.
